When it comes to cancer, early detection can make a significant difference. At NexGen Health in San Jose, we offer the Galleri® multi-cancer early detection test: a powerful tool designed to identify signs of more than 50 types of cancer through a simple blood draw. It’s a major step forward in preventive care and one more way we’re helping patients take control of their long-term health.
What is the Galleri Test?
The Galleri test is a blood-based screening tool that looks for molecular signals linked to multiple types of cancer. Developed by GRAIL, this test analyzes methylation patterns in fragments of DNA that tumors release into the bloodstream. These markers help identify if a cancer signal is present and where in the body it may be coming from.
It’s a new category of screening that goes beyond the five cancers traditionally covered by routine tests. Instead of waiting for symptoms to appear, Galleri gives you the chance to detect a potential issue before it becomes harder to treat.
How the Test Works
Getting the Galleri test at NexGen Health is straightforward. After a simple blood draw, your sample is sent to a CLIA-certified lab, where it’s analyzed for cancer-associated DNA patterns. If a signal is detected, the test can often indicate the tissue where the cancer may have started, giving your medical team a helpful starting point for follow-up evaluations.
It’s important to know that Galleri is not a diagnostic tool. A positive result doesn’t confirm cancer; further diagnostic tests will be needed to investigate.
Who Should Consider the Galleri Test?
The test is recommended for adults who are at higher risk for cancer, especially those aged 50 or older. It’s not meant to replace routine screenings like mammograms or colonoscopies but to be used alongside them as part of a broader preventive health strategy.
At NexGen Health, we’ll help determine whether the Galleri test fits into your care plan based on your age, medical history, and personal health goals.
What Makes Galleri Different
Most cancer screenings only look for one type of cancer at a time. Galleri looks for signals linked to over 50. It’s especially valuable for detecting cancers that don’t have existing screening guidelines, like pancreatic, ovarian, or liver cancer.
According to the American Family Physician Journal, the test has a specificity rate of 99.5% and can identify the cancer’s likely origin in nearly 89% of positive cases. That level of precision helps patients and providers act quickly and confidently.
What to Know Before You Test
The Galleri test is FDA-authorized under CLIA but not formally FDA-approved yet. It’s currently available through select medical practices, including NexGen Health. Because it’s a newer test, insurance coverage may vary. Our team can help answer your questions and explain your payment options during your consultation.
FAQs
How accurate is the Galleri test?
While not perfect, it has shown a high specificity rate and a strong ability to detect the likely tissue of origin in positive results.
Can it replace my regular screenings?
No. Galleri is meant to supplement, not replace, standard cancer screenings your doctor recommends.
How long do results take?
Most patients receive their results in about two weeks.
Will insurance cover the test?
Coverage depends on your plan. Our staff can help you understand the cost and explore options.
Schedule Your Galleri Test at NexGen Health
If you’re looking for a smarter way to stay ahead of cancer, the Galleri test may be right for you. NexGen Health in San Jose is ready to help you take the next step toward personalized, preventive care. Schedule a consultation today to learn more.
